Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway

Ischemia cerebral stroke is one of the common neurological diseases with severe inflammatory response and neuron death. The inhibition of colony-stimulating factor 1 receptor (CSF1R) which especially expressed in microglia/macrophage exerted neuroprotection in stroke. However, the underlying neuroin...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoxue Du, Yuzhen Xu, Shijia Chen, Marong Fang
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2020/8825954
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850210406525566976
author Xiaoxue Du
Yuzhen Xu
Shijia Chen
Marong Fang
author_facet Xiaoxue Du
Yuzhen Xu
Shijia Chen
Marong Fang
author_sort Xiaoxue Du
collection DOAJ
description Ischemia cerebral stroke is one of the common neurological diseases with severe inflammatory response and neuron death. The inhibition of colony-stimulating factor 1 receptor (CSF1R) which especially expressed in microglia/macrophage exerted neuroprotection in stroke. However, the underlying neuroinflammatory regulation effects of CSF1R in ischemia stroke are not clear. In this study, cerebral ischemia stroke mice model was established. The C57/B6J mice were administered with Ki20227, a CSF1R inhibitor, by gavage for 7 consecutive days (0.002 mg/kg/day) before modeling. The Rota-Rod test and neurobehavioral score test were investigated to assess neurobehavioral functions. The area of infarction was assessed by 2, 3, 5-triphenyltetrazolium chloride (TTC) staining. The mRNA expressions of M1/M2 microglia markers were evaluated by real-time PCR. Immunofluorescence and Western blot were utilized to detect the changes of Iba1 and NLRP3 pathway proteins. Results showed that neurobehavioral function improvement was demonstrated by an increased stay time on the Rota-Rod test and a decreased neurobehavioral score in the Ki20227 treatment group. The area of infarction reduced in Ki20227 group when compared to the stroke group. Moreover, the mRNA expression of M1 microglia markers (TNF-α and iNOS) decreased while M2 microglia markers (IL-10 and Arg-1) increased. Meanwhile, compared to the stroke and stroke+PBS group, Ki20227 administration downregulated the expression of NLRP3, active caspase 1, and NF-κB protein in the ischemia penumbra of Ki20227 treatment group mice. In short, the CSF1R inhibitor, Ki20227, played vital neuroprotective roles in ischemia cerebral stroke mice, and the mechanisms may be via inhibiting microglia M1 polarization and NLRP3 inflammasome pathway activation. Our study provides a potential new target for the treatment of ischemic stroke injury.
format Article
id doaj-art-9462bfdcb0d443c3b3d6be2103b92d42
institution OA Journals
issn 2090-5904
1687-5443
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-9462bfdcb0d443c3b3d6be2103b92d422025-08-20T02:09:47ZengWileyNeural Plasticity2090-59041687-54432020-01-01202010.1155/2020/88259548825954Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 PathwayXiaoxue Du0Yuzhen Xu1Shijia Chen2Marong Fang3Institute of Neuroscience, Zhejiang University School of Medicine, Hangzhou, 310006 Zhejiang, ChinaDepartment of Neurology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, ChinaInstitute of Neuroscience, Zhejiang University School of Medicine, Hangzhou, 310006 Zhejiang, ChinaInstitute of Neuroscience, Zhejiang University School of Medicine, Hangzhou, 310006 Zhejiang, ChinaIschemia cerebral stroke is one of the common neurological diseases with severe inflammatory response and neuron death. The inhibition of colony-stimulating factor 1 receptor (CSF1R) which especially expressed in microglia/macrophage exerted neuroprotection in stroke. However, the underlying neuroinflammatory regulation effects of CSF1R in ischemia stroke are not clear. In this study, cerebral ischemia stroke mice model was established. The C57/B6J mice were administered with Ki20227, a CSF1R inhibitor, by gavage for 7 consecutive days (0.002 mg/kg/day) before modeling. The Rota-Rod test and neurobehavioral score test were investigated to assess neurobehavioral functions. The area of infarction was assessed by 2, 3, 5-triphenyltetrazolium chloride (TTC) staining. The mRNA expressions of M1/M2 microglia markers were evaluated by real-time PCR. Immunofluorescence and Western blot were utilized to detect the changes of Iba1 and NLRP3 pathway proteins. Results showed that neurobehavioral function improvement was demonstrated by an increased stay time on the Rota-Rod test and a decreased neurobehavioral score in the Ki20227 treatment group. The area of infarction reduced in Ki20227 group when compared to the stroke group. Moreover, the mRNA expression of M1 microglia markers (TNF-α and iNOS) decreased while M2 microglia markers (IL-10 and Arg-1) increased. Meanwhile, compared to the stroke and stroke+PBS group, Ki20227 administration downregulated the expression of NLRP3, active caspase 1, and NF-κB protein in the ischemia penumbra of Ki20227 treatment group mice. In short, the CSF1R inhibitor, Ki20227, played vital neuroprotective roles in ischemia cerebral stroke mice, and the mechanisms may be via inhibiting microglia M1 polarization and NLRP3 inflammasome pathway activation. Our study provides a potential new target for the treatment of ischemic stroke injury.http://dx.doi.org/10.1155/2020/8825954
spellingShingle Xiaoxue Du
Yuzhen Xu
Shijia Chen
Marong Fang
Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway
Neural Plasticity
title Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway
title_full Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway
title_fullStr Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway
title_full_unstemmed Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway
title_short Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway
title_sort inhibited csf1r alleviates ischemia injury via inhibition of microglia m1 polarization and nlrp3 pathway
url http://dx.doi.org/10.1155/2020/8825954
work_keys_str_mv AT xiaoxuedu inhibitedcsf1ralleviatesischemiainjuryviainhibitionofmicrogliam1polarizationandnlrp3pathway
AT yuzhenxu inhibitedcsf1ralleviatesischemiainjuryviainhibitionofmicrogliam1polarizationandnlrp3pathway
AT shijiachen inhibitedcsf1ralleviatesischemiainjuryviainhibitionofmicrogliam1polarizationandnlrp3pathway
AT marongfang inhibitedcsf1ralleviatesischemiainjuryviainhibitionofmicrogliam1polarizationandnlrp3pathway